Abbott Strikes Deal With FDA To Reopen Baby Formula Plant At Center Of National Shortage

 Abbott Laboratories has reached an agreement with the Food and Drug Administration to reopen its baby formula plant in Sturgis, Michigan, the company announced Monday, raising hopes that a national formula shortage—fueled partly by the Sturgis plant’s closure due to safety concerns—will be over in a matter of weeks.